{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:53:06Z","timestamp":1791143586333,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:00:00Z","timestamp":1791072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:00:00Z","timestamp":1791072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271996"],"award-info":[{"award-number":["82271996"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ultrasound"],"DOI":"10.1007\/s40477-026-01235-8","type":"journal-article","created":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:55:17Z","timestamp":1791096917000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quantitative analysis of tumor perfusion via contrast-enhanced ultrasound to predict the neoadjuvant chemotherapy efficacy for children with hepatoblastoma"],"prefix":"10.1007","author":[{"given":"Meixi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangliang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1828-0878","authenticated-orcid":false,"given":"Luyao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,4]]},"reference":[{"key":"1235_CR1","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1148\/rg.312105201","volume":"31","author":"EM Chung","year":"2011","unstructured":"Chung EM, Lattin GE, Cube R et al (2011) From the archives of the AFIP: pediatric liver masses: radiologic-pathologic correlation. Part 2. Malignant tumors. Radiographics 31:483\u2013507. https:\/\/doi.org\/10.1148\/rg.312105201","journal-title":"Radiographics"},{"key":"1235_CR2","doi-asserted-by":"publisher","first-page":"445","DOI":"10.5582\/bst.2023.01311","volume":"17","author":"Y Cao","year":"2024","unstructured":"Cao Y, Wu S, Tang H (2024) An update on diagnosis and treatment of hepatoblastoma. Biosci Trends 17:445\u2013457. https:\/\/doi.org\/10.5582\/bst.2023.01311","journal-title":"Biosci Trends"},{"key":"1235_CR3","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S1470-2045(16)30598-8","volume":"18","author":"RL Meyers","year":"2017","unstructured":"Meyers RL, Maibach R, Hiyama E et al (2017) Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the children\u2019s hepatic tumors international collaboration. Lancet Oncol 18:122\u2013131. https:\/\/doi.org\/10.1016\/S1470-2045(16)30598-8","journal-title":"Lancet Oncol"},{"key":"1235_CR4","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s11912-022-01230-2","volume":"24","author":"PV Wu","year":"2022","unstructured":"Wu PV, Rangaswami A (2022) Current approaches in hepatoblastoma-new biological insights to inform therapy. Curr Oncol Rep 24:1209\u20131218. https:\/\/doi.org\/10.1007\/s11912-022-01230-2","journal-title":"Curr Oncol Rep"},{"key":"1235_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/MOP.0000000000000042","volume":"26","author":"RL Meyers","year":"2014","unstructured":"Meyers RL, Tiao G, de Ville de Goyet J et al (2014) Hepatoblastoma state of the art: pre-treatment extent of disease, surgical resection guidelines and the role of liver transplantation. Curr Opin Pediatr 26:29\u201336. https:\/\/doi.org\/10.1097\/MOP.0000000000000042","journal-title":"Curr Opin Pediatr"},{"key":"1235_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11030407","volume":"11","author":"JJG Marin","year":"2019","unstructured":"Marin JJG, Cives-Losada C, Asensio M et al (2019) Mechanisms of anticancer drug resistance in hepatoblastoma. Cancers (Basel) 11:407. https:\/\/doi.org\/10.3390\/cancers11030407","journal-title":"Cancers (Basel)"},{"key":"1235_CR7","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jhep.2023.05.031","volume":"79","author":"A Claver\u00eda-Cabello","year":"2023","unstructured":"Claver\u00eda-Cabello A, Herranz JM, Latasa MU et al (2023) Identification and experimental validation of druggable epigenetic targets in hepatoblastoma. J Hepatol 79:989\u20131005. https:\/\/doi.org\/10.1016\/j.jhep.2023.05.031","journal-title":"J Hepatol"},{"key":"1235_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32473-z","volume":"13","author":"H Song","year":"2022","unstructured":"Song H, Bucher S, Rosenberg K et al (2022) Single-cell analysis of hepatoblastoma identifies tumor signatures that predict chemotherapy susceptibility using patient-specific tumor spheroids. Nat Commun 13:4878. https:\/\/doi.org\/10.1038\/s41467-022-32473-z","journal-title":"Nat Commun"},{"key":"1235_CR9","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1158\/2159-8290.CD-20-1809","volume":"11","author":"TZ Hirsch","year":"2021","unstructured":"Hirsch TZ, Pilet J, Morcrette G et al (2021) Integrated genomic analysis identifies driver genes and cisplatin-resistant progenitor phenotype in pediatric liver cancer. Cancer Discov 11:2524\u20132543. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-1809","journal-title":"Cancer Discov"},{"key":"1235_CR10","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s00247-023-05793-5","volume":"54","author":"Y Chen","year":"2024","unstructured":"Chen Y, Froelich MF, Tharmaseelan H et al (2024) Computed tomography imaging phenotypes of hepatoblastoma identified from radiomics signatures are associated with the efficacy of neoadjuvant chemotherapy. Pediatr Radiol 54:58\u201367. https:\/\/doi.org\/10.1007\/s00247-023-05793-5","journal-title":"Pediatr Radiol"},{"key":"1235_CR11","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00432-024-05746-x","volume":"150","author":"Y Yang","year":"2024","unstructured":"Yang Y, Wang H, Si J et al (2024) Predicting response of hepatoblastoma primary lesions to neoadjuvant chemotherapy through contrast-enhanced computed tomography radiomics. J Cancer Res Clin Oncol 150:223. https:\/\/doi.org\/10.1007\/s00432-024-05746-x","journal-title":"J Cancer Res Clin Oncol"},{"key":"1235_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ymeth.2020.05.022","volume":"188","author":"A Ibrahim","year":"2021","unstructured":"Ibrahim A, Primakov S, Beuque M et al (2021) Radiomics for precision medicine: current challenges, future prospects, and the proposal of a new framework. Methods 188:20\u201329. https:\/\/doi.org\/10.1016\/j.ymeth.2020.05.022","journal-title":"Methods"},{"issue":"Suppl 6","key":"1235_CR13","doi-asserted-by":"publisher","first-page":"F89","DOI":"10.1007\/s10406-007-0233-6","volume":"17","author":"N Lassau","year":"2007","unstructured":"Lassau N, Chami L, Benatsou B et al (2007) Dynamic contrast-enhanced ultrasonography (DCE-US) with quantification of tumor perfusion: a new diagnostic tool to evaluate the early effects of antiangiogenic treatment. Eur Radiol 17(Suppl 6):F89-98. https:\/\/doi.org\/10.1007\/s10406-007-0233-6","journal-title":"Eur Radiol"},{"key":"1235_CR14","doi-asserted-by":"publisher","first-page":"933","DOI":"10.2214\/AJR.15.15789","volume":"206","author":"MB McCarville","year":"2016","unstructured":"McCarville MB, Coleman JL, Guo J et al (2016) Use of quantitative dynamic contrast-enhanced ultrasound to assess response to antiangiogenic therapy in children and adolescents with solid malignancies: a pilot study. AJR Am J Roentgenol 206:933\u2013939. https:\/\/doi.org\/10.2214\/AJR.15.15789","journal-title":"AJR Am J Roentgenol"},{"key":"1235_CR15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/jjco\/hyv215","volume":"46","author":"A Amioka","year":"2016","unstructured":"Amioka A, Masumoto N, Gouda N et al (2016) Ability of contrast-enhanced ultrasonography to determine clinical responses of breast cancer to neoadjuvant chemotherapy. Jpn J Clin Oncol 46:303\u2013309. https:\/\/doi.org\/10.1093\/jjco\/hyv215","journal-title":"Jpn J Clin Oncol"},{"key":"1235_CR16","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1158\/1078-0432.CCR-09-2175","volume":"16","author":"N Lassau","year":"2010","unstructured":"Lassau N, Koscielny S, Albiges L et al (2010) Metastatic renal cell carcinoma treated with sunitinib: early evaluation of treatment response using dynamic contrast-enhanced ultrasonography. Clin Cancer Res 16:1216\u20131225. https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-2175","journal-title":"Clin Cancer Res"},{"key":"1235_CR17","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1148\/radiol.10091870","volume":"258","author":"N Lassau","year":"2011","unstructured":"Lassau N, Koscielny S, Chami L et al (2011) Advanced hepatocellular carcinoma: early evaluation of response to bevacizumab therapy at dynamic contrast-enhanced US with quantification--preliminary results. Radiology 258:291\u2013300. https:\/\/doi.org\/10.1148\/radiol.10091870","journal-title":"Radiology"},{"key":"1235_CR18","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3760\/cma.j.issn.0253-3006.2017.10.003","volume":"38","author":"Committee CA-CAP, Group CMAPO","year":"2017","unstructured":"Committee CA-CAP, Group CMAPO (2017) Expert consensus for multidisciplinary management of hepatoblastoma (CCCG-HB-2016). Chin J Pediatr Surg 38:733\u2013739. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-3006.2017.10.003","journal-title":"Chin J Pediatr Surg"},{"key":"1235_CR19","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1007\/s00247-018-4078-z","volume":"48","author":"AJ Towbin","year":"2018","unstructured":"Towbin AJ, Meyers RL, Woodley H et al (2018) 2017 PRETEXT: radiologic staging system for primary hepatic malignancies of childhood revised for the Paediatric Hepatic International Tumour Trial (PHITT). Pediatr Radiol 48:536\u2013554. https:\/\/doi.org\/10.1007\/s00247-018-4078-z","journal-title":"Pediatr Radiol"},{"key":"1235_CR20","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228\u2013247. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026","journal-title":"Eur J Cancer"},{"key":"1235_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1055\/s-0042-107411","volume":"37","author":"K Seitz","year":"2016","unstructured":"Seitz K, Strobel D (2016) A milestone: approval of CEUS for diagnostic liver imaging in adults and children in the USA. Ultraschall Med 37:229\u2013232. https:\/\/doi.org\/10.1055\/s-0042-107411","journal-title":"Ultraschall Med"},{"key":"1235_CR22","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1007\/s00247-021-04998-w","volume":"51","author":"K Darge","year":"2021","unstructured":"Darge K, Back SJ, Barth RA et al (2021) Starting a pediatric contrast ultrasound service: made simple! Pediatr Radiol 51:2139\u20132146. https:\/\/doi.org\/10.1007\/s00247-021-04998-w","journal-title":"Pediatr Radiol"},{"key":"1235_CR23","doi-asserted-by":"publisher","first-page":"757","DOI":"10.7863\/jum.2007.26.6.757","volume":"26","author":"Z Wang","year":"2007","unstructured":"Wang Z, Tang J, An L et al (2007) Contrast-enhanced ultrasonography for assessment of tumor vascularity in hepatocellular carcinoma. J Ultrasound Med 26:757\u2013762. https:\/\/doi.org\/10.7863\/jum.2007.26.6.757","journal-title":"J Ultrasound Med"},{"key":"1235_CR24","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1148\/radiol.2017174012","volume":"283","author":"B-B Chen","year":"2017","unstructured":"Chen B-B, Hsu C-Y, Yu C-W et al (2017) Dynamic contrast-enhanced MR imaging of advanced hepatocellular carcinoma: comparison with the liver parenchyma and correlation with the survival of patients receiving systemic therapy. Radiology 283:923. https:\/\/doi.org\/10.1148\/radiol.2017174012","journal-title":"Radiology"},{"key":"1235_CR25","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/RCT.0000000000000807","volume":"43","author":"D Ippolito","year":"2019","unstructured":"Ippolito D, Querques G, Pecorelli A et al (2019) Diagnostic value of quantitative perfusion computed tomography technique in the assessment of tumor response to sorafenib in patients with advanced hepatocellular carcinoma. J Comput Assist Tomogr 43:206\u2013213. https:\/\/doi.org\/10.1097\/RCT.0000000000000807","journal-title":"J Comput Assist Tomogr"},{"key":"1235_CR26","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1097\/00000478-199312000-00008","volume":"17","author":"R Saxena","year":"1993","unstructured":"Saxena R, Leake JL, Shafford EA et al (1993) Chemotherapy effects on hepatoblastoma. A histological study. Am J Surg Pathol 17:1266\u20131271. https:\/\/doi.org\/10.1097\/00000478-199312000-00008","journal-title":"Am J Surg Pathol"},{"key":"1235_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2016.09.038","author":"E Hiyama","year":"2016","unstructured":"Hiyama E, Hishiki T, Watanabe K et al (2016) Resectability and tumor response after preoperative chemotherapy in hepatoblastoma treated by the Japanese study group for pediatric liver tumor (JPLT)-2 protocol. J Pediatr Surg. https:\/\/doi.org\/10.1016\/j.jpedsurg.2016.09.038","journal-title":"J Pediatr Surg"},{"key":"1235_CR28","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1200\/JCO.2009.22.4857","volume":"28","author":"J Zs\u00edros","year":"2010","unstructured":"Zs\u00edros J, Maibach R, Shafford E et al (2010) Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study. J Clin Oncol 28:2584\u20132590. https:\/\/doi.org\/10.1200\/JCO.2009.22.4857","journal-title":"J Clin Oncol"}],"container-title":["Journal of Ultrasound"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40477-026-01235-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40477-026-01235-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40477-026-01235-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:01:40Z","timestamp":1791140500000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40477-026-01235-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,4]]},"references-count":28,"alternative-id":["1235"],"URL":"https:\/\/doi.org\/10.1007\/s40477-026-01235-8","relation":{},"ISSN":["1876-7931"],"issn-type":[{"value":"1876-7931","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,4]]},"assertion":[{"value":"12 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional review board of the First Affiliated Hospital of Sun Yat sen University (15 Aug 2022\/No. [2022] 367).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}